<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="LIRI-JP_PCAWG_RNA-Seq_Star" center_name="ICGC" broker_name="EGA" accession="EGAD00001003547">
		<TITLE>ICGC PCAWG Dataset: LIRI-JP_PCAWG_RNA-Seq_Star</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for RNA-Seq BAM aligned using Star. Project: LIRI-JP.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001312115"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312116"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312117"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312118"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312119"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312120"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312121"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312122"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312123"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312124"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312125"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312126"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312127"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312128"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312129"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312130"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312131"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312132"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312133"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312134"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312135"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312136"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312137"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312138"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312139"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312140"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312141"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312142"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312143"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312144"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312145"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312146"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312147"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312148"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312149"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312150"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312151"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312152"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312153"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312154"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312155"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312156"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312157"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312158"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312159"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312160"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312161"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312162"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312163"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312164"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312165"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312166"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312167"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312168"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312169"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312170"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312171"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312172"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312173"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312174"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312175"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312176"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312177"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312178"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312179"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312180"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312195"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312196"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312197"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312224"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312240"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312241"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312242"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312243"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312244"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>